Autologous gene therapy versus allogeneic transplantation for sickle cell disease and transfusion-dependent β-thalassemia: Choosing between 2 definitive therapies
Autologous gene therapy versus allogeneic transplantation for sickle cell disease and transfusion-dependent β-thalassemia: Choosing between 2 definitive therapies. // Seminars in Hematology. – URL: https://www.sciencedirect.com/science/article/pii/S0037196326000892?dgcid=rss_sd_all
Autologous gene therapy versus allogeneic transplantation for sickle cell disease and transfusion-dependent β-thalassemia: Choosing between 2 definitive therapies. Seminars in Hematology. https://www.sciencedirect.com/science/article/pii/S0037196326000892?dgcid=rss_sd_all
“Autologous gene therapy versus allogeneic transplantation for sickle cell disease and transfusion-dependent β-thalassemia: Choosing between 2 definitive therapies.” Seminars in Hematology.
@article{article95184,
title = {Autologous gene therapy versus allogeneic transplantation for sickle cell disease and transfusion-dependent β-thalassemia: Choosing between 2 definitive therapies},
journal = {Seminars in Hematology},
url = {https://www.sciencedirect.com/science/article/pii/S0037196326000892?dgcid=rss_sd_all}
}